Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126787181 | 12678718 | 1 | I | 2016 | 20160811 | 20160823 | 20160823 | PER | US-ASTRAZENECA-2016SE87267 | ASTRAZENECA | 74.00 | YR | M | Y | 77.10000 | KG | 20160824 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126787181 | 12678718 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400, EVERY 12 HOURS | U | U | 1150132 | 202450 | INHALATION POWDER | ||||||
| 126787181 | 12678718 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40.0MG UNKNOWN | 0 | 40 | MG | TABLET | |||||||
| 126787181 | 12678718 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 19810 | 40 | MG | QD | ||||||||
| 126787181 | 12678718 | 4 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | AT NIGHT | 0 | ||||||||||
| 126787181 | 12678718 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | .088 | MG | |||||||||
| 126787181 | 12678718 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 300 | MG | |||||||||
| 126787181 | 12678718 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | 125 | MG | |||||||||
| 126787181 | 12678718 | 8 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126787181 | 12678718 | 9 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 126787181 | 12678718 | 10 | C | MEGESTROL HCETATE | 2 | Oral | 0 | QD | |||||||||||
| 126787181 | 12678718 | 11 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500.0MG UNKNOWN | 0 | 500 | MG | ||||||||
| 126787181 | 12678718 | 12 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126787181 | 12678718 | 1 | Chronic obstructive pulmonary disease |
| 126787181 | 12678718 | 2 | Blood pressure abnormal |
| 126787181 | 12678718 | 3 | Gastrooesophageal reflux disease |
| 126787181 | 12678718 | 4 | Blood cholesterol abnormal |
| 126787181 | 12678718 | 5 | Thyroid disorder |
| 126787181 | 12678718 | 6 | Diabetes mellitus |
| 126787181 | 12678718 | 7 | Blood pressure abnormal |
| 126787181 | 12678718 | 8 | Blood pressure abnormal |
| 126787181 | 12678718 | 9 | Blood pressure abnormal |
| 126787181 | 12678718 | 10 | Prostate cancer |
| 126787181 | 12678718 | 11 | Diabetes mellitus |
| 126787181 | 12678718 | 12 | Dyspnoea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126787181 | 12678718 | Dyspnoea | |
| 126787181 | 12678718 | Intentional product misuse | |
| 126787181 | 12678718 | Off label use | |
| 126787181 | 12678718 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126787181 | 12678718 | 1 | 201603 | 0 |